Erratum: Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the national psoriasis foundation surveys, 2003-2011 (JAMA Dermatology (2013): 149 10 (1180-1185) DOI:10.1001/jamadermatol.2013.5264);Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the National Psoriasis Foundation Surveys, 2003-2011

JAMA Dermatology

Volumn 149, Issue 10, 2013, Pages 1180-1185

  Armstrong, April W ^a   Robertson, Andrew D ^b   Wu, Julie ^a   Schupp, Clayton ^a   Lebwohl, Mark G ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b National Psoriasis Foundation   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALEFACEPT; BIOLOGICAL PRODUCT; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; GOLIMUMAB; INFLIXIMAB; METHOTREXATE; TOPICAL AGENT;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG USE; DRUG WITHDRAWAL; EXCIMER LASER; FEMALE; HEALTH CARE QUALITY; HEALTH SURVEY; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUVA; TREND STUDY; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNDERTREATMENT; UNITED STATES; UNSPECIFIED SIDE EFFECT;

EID: 84885935651     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.9598     Document Type: Erratum

References (6)

1. Enamandram M, Kimball AB. Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol. 2013;133(2): 287-289.
2. Melnikova I. Psoriasis market. Nat Rev Drug Discov. 2009;8(10): 767-768.
3. Sampogna F, Chren MM, Melchi CF, Pasquini P, Tabolli S, Abeni D; Italian Multipurpose Psoriasis Research on Vital Experiences (Improve) Study Group. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis. Br J Dermatol. 2006;154(2): 325-331.
4. TaylorWJ. Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability. Curr Rheumatol Rep. 2012;14(4): 369-374.
5. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? results of National Psoriasis Foundation survey. J AmAcad Dermatol. 2007;57(6): 957-962.
6. Finlay AY, Ortonne JP. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy. J Cutan Med Surg. 2004;8(5): 310-320.